111 (NASDAQ: YI)
111 Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
111 Company Info
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
News & Analysis
This Is the Only Chinese Stock I Would Buy Right Now
A diamond in the rough is a pretty rare find, especially among Chinese stocks.
3 Top Chinese Stocks to Watch in June
Looking to invest in America's top rival? Here are your best bets.
Is 111 the Next Teladoc?
Both companies boast triple-digit revenue growth, and both can offer investors big stock gains.
Why 111 Stock Soared, Then Dropped Thursday
The Chinese healthcare platform is being compared to some successful U.S. peers.
Valuation
Earnings Transcripts
111, inc (YI) Q3 2021 Earnings Call Transcript
YI earnings call for the period ending September 30, 2021.
111, inc (YI) Q2 2021 Earnings Call Transcript
YI earnings call for the period ending June 30, 2021.
111 Inc (YI) Q1 2021 Earnings Call Transcript
YI earnings call for the period ending March 31, 2021.
111 Inc (YI) Q4 2020 Earnings Call Transcript
YI earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.